Physician profile
Sarah E Pucillo
NPI 1770808065
$2,172.20
in general payments reported to CMS, 2019-2025
26 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.70 · 2020: $48.82 · 2021: $315 · 2022: $385 · 2023: $513 · 2024: $508 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,244 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,243.98 |
| Education | $113.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $249.94 | 2019-2025 | Coolseal Generator, Acessa Provu System, Novasure |
| Astellas Pharma US INC | $248.02 | 2023-2025 | Veozah |
| Abbvie INC. | $239.06 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $158.80 | 2021-2025 | |
| Organon LLC | $155.35 | 2021-2025 | Nexplanon |
| Coopersurgical, INC. | $152.20 | 2021-2025 | Paragard T 380a, Sos, Paragard T 380a |
| Medtronic, INC. | $137.17 | 2024 | Abre |
| Exeltis, USA INC. | $106.49 | 2020-2023 | Slynd |
| Ethicon US, LLC | $102.89 | 2023 | Surgiflo Hemostatic Matrix, Vistaseal, Ethicon |
| Merck Sharp & Dohme LLC | $90.83 | 2020-2024 | Gardasil 9, Gardasil |
| Pfizer INC. | $87.55 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.88 | 2022-2025 | |
| Therapeuticsmd, INC. | $62.89 | 2019-2022 | |
| Avion Pharmaceuticals | $50.62 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $29.53 | 2025 | Myfembree |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $27.77 | 2022 | |
| Myovant Sciences INC. | $23.94 | 2022 | |
| Sage Therapeutics, LLC | $23.19 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $23.19 | 2025 | Qelbree |
| Exact Sciences Corporation | $21.00 | 2023 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $20.49 | 2021 | |
| Smith+Nephew, INC. | $19.86 | 2025 | Pico |
| Meditrina | $17.42 | 2024 | |
| Millicent US INC | $16.52 | 2025 | Femring, Intrarosa |
| Vertical Pharmaceuticals, LLC | $15.90 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Pucillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.